Get started
Live feed
·
SECFilingvia Quantisnow
Genprex Inc. logo

GNPX: SEC Form S-3 filed by Genprex Inc.

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for GNPX

Across the 19 sessions after earlier GNPX headlines, the stock closed higher 5 times and lower 13 times, with a median move of 6.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

GNPX close-to-close change in the session after earlier headlines
SessionEarlier headlineGNPXSPY
May 26, 2026Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting-6.0%+0.7%
May 14, 2026Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting+1.2%+0.8%
Apr 30, 2026Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer+12.1%+1.0%
Apr 28, 2026Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting-0.5%-0.5%
Apr 22, 2026Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting-6.4%+1.0%
Apr 21, 2026Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy-5.6%-0.7%
Quantisnow market dataNASDAQ
Genprex Inc. logo
GNPX
Genprex Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2018
Get push alerts for GNPX

Follow GNPX and get a push notification the moment its next story breaks.

Full GNPX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GNPX (Genprex Inc.) and more on Quantisnow.